在肝细胞癌中,COPS5通过稳定MK2触发铁死防御,从而触发COPS5的铁死防御
Ai-Ling Luo1,2, Wen-Ying Zheng1, Qiong Zhang1
1Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University, Guangzhou, 510095, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|April 8, 2025
概括
COP9信号酶子单元5 (COPS5) 通过抑制铁亡,驱动肝细胞癌 (HCC) 中的索拉芬尼抗性. 用sorafenib抑制COPS5为HCC患者提供了潜在的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 索拉菲尼布是先进肝细胞癌 (HCC) 的一线治疗方法.
- 耐药性限制了索拉费尼布在HCC中的临床益处.
- 铁亡是一种细胞死亡途径,与癌症治疗有关.
研究的目的:
- 确定HCC中索拉费尼布耐药性的机制.
- 研究COPS5在铁亡和索拉芬尼布耐药性中的作用.
- 探索针对HCC中COPS5的治疗策略.
主要方法:
- 全基因组的CRISPR/Cas9淘汰选. 这是一个非常好的选择.
- 在HCC细胞系中的功能研究.
- 对临床HCC样本的分析.
主要成果:
- 确定COPS5是索拉费尼布耐药性的驱动因素,也是HCC中铁亡的抑制剂.
- 在HCC中,COPS5过度表达是常见的,并且与预后不佳有关.
- COPS5稳定了MK2,激活了hspb1,一种铁灭抑制剂.
- 索拉费尼布通过ATF4.4诱导COPS5的表达.
- 抑制COPS5/MK2与索拉费尼布协同作用,抑制HCC.
结论:
- 通过MK2-HSPB1轴,COPS5在HCC中的铁灭防御和索拉芬尼抗性中发挥着关键作用.
- 针对COPS5/MK2与索拉费尼布结合的治疗是HCC的有希望的治疗策略.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
07:47Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
2.2K
相关概念视频
Liver Regeneration
3.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K
Necrosis
4.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
